Schroder Investment Management Group’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.92M Buy
1,746,643
+305,584
+21% +$2.03M 0.01% 673
2026
Q1
$9.54M Buy
1,441,059
+435,075
+43% +$5.67M 0.01% 674
2025
Q4
$17.3M Buy
1,005,984
+450,440
+81% +$4.58M 0.01% 542
2025
Q3
$3.96M Sell
555,544
-65,834
-11% -$533K ﹤0.01% 811
2025
Q2
$4.04M Buy
621,378
+142,109
+30% +$938K ﹤0.01% 807
2025
Q1
$4.13M Buy
+479,269
New +$5.24M ﹤0.01% 799

Other funds holding WVE

Schroder Investment Management Group's WVE Position: Q2 2026 in Review

Schroder Investment Management Group increased its Wave Life Sciences (WVE) stake by 21% in Q2 2026, buying an estimated $2.03M and bringing the position to 1,746,643 shares worth $9.92M. The position accounts for 0.01% of the portfolio, ranked #673.

Schroder Investment Management Group first reported a position in WVE in Q1 2025 and has held it in 6 quarters since. The position peaked at $17.3M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Schroder Investment Management Group held 1,746,643 shares of Wave Life Sciences worth $9.92M as of Q2 2026.
  • Schroder Investment Management Group bought 305,584 Wave Life Sciences shares in Q2 2026, an estimated $2.03M.
  • Wave Life Sciences made up 0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #673 holding.
  • Schroder Investment Management Group first reported a position in Wave Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • Schroder Investment Management Group's Wave Life Sciences position peaked at $17.3M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.